Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2

Human Pathology

Volumn 27, Issue 7, 1996, Pages 738-744

  Wasik, Mariusz A ^a   Sackstein, Robert ^b   Novick, Daniela ^b   Butmarc, Janet R ^b   Zhang, Qian ^b   Vonderheid, Eric C ^b   Kadin, Marshall E ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

CD56; cutaneous; IL 2; Lymphoma; NK cell; serum; T cell

Indexed keywords

CD56 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN RECEPTOR;

AGED; ARTICLE; BLOOD LEVEL; CASE REPORT; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; MALE; NATURAL KILLER CELL; T CELL LYMPHOMA;

EID: 0030001151     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90408-6     Document Type: Article

References (45)

1. Kern WF, Spier CM, Hanneman EH, et al: Neural cell adhesion molecule-positive peripheral t-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood 79:2432-2437, 1992
2. Wong KF, Chan JKC, Ng CS, et al: CD56 (NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/ mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. HUM PATHOL 23:798-804, 1992
3. Chan JKC, Yip T, Ng CS, et al: Strong association of Epstein-Barr virus with CD56-positive nasal/nasopharyngeal T-cell lymphomas of the upper aerodigestive tract. United States and Canadian Academy of Pathology, March 12-18, 1994 (abstr)
4. Wong KF, Chan JK, Ng CS: NCAM (CD56)-positive malignant lymphoma. Blood 80:2431, 1992 [letter; comment]
5. Kern WF: NCAM (CD56)-positive malignant lymphoma (a response). Blood 80:2432, 1992 (letter)
6. Medeiros LJ, Jaffe ES: Pathology of malignant lymphomas. In: Wiernik PH, Canellos GP, Kyle RA, et al (eds): Neoplastic Diseases of the Blood. New York Churchill Livingstone. 1991, pp 631-662
7. Strickler JG, Meneses MF, Habermann TM, et al: Polymorphic reticulosis: A reappraisal. HUM PATHOL 25:659-665, 1994
8. Suzumiya J, Takeshita M, Kimura N, et al: Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 83:2255-2260, 1994
9. Paul WE, Seder RA: Lymphocyte Responses and cytokines. Cell 76:241-251, 1994
10. Romagni S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
11. Cogan E, Schandene L, Crusiax A, et al: Brief report: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N EnglJ Med 330:535-538, 1994
12. Vowels BR, Cassin M, Vonderheit EC, et al: Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion resembles murine Th2 cells. J Invest Dermatol 99:90-94, 1992
13. Dummer R, Kohl O, Gillessen J, et al: Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch Dermatol 129:433-436, 1993
14. Vowels BR, Lessin SR, Cassin M, et al: Th2 cytokine expression in skin in cutaneous T cell lymphoma. J Invest Dermatol 103:669-673, 1994
15. Muramoto LM, Kadin ME: Improved detection of lymphoid cell surface antigens in tissues fixed in periodate-lysine-paraformaldehyde (PLP). Am J Clin Pathol 1987;88:589-595
16. Wasik MA, Sioutos N, Tuttle M, et al: Constitutive secretion of soluble IL-2 receptor by human T-cel! lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. Am J Pathol 144:1089-1097, 1994
17. Montone KT, Friedman H, Hodinka R, et al: In-situ hybridization for Epstein-Barr virus Not I region in posttransplant lymphoproliferative disorders. Mod Pathol 5:292-302, 1992
18. Novick D, Englemann H, Wallach D, et al: Monoclonal antibodies to the soluble human IL-6 receptor: Affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 10:137-146, 1991
19. Wasik M, Muirhead D, Rubocki R, et al: Enzyme immunoassay with cell suspensions: studies on reactions between serum antibodies and cell-surface antigens. Int Archs Allergy Appl Immunol 81:269-275, 1986
20. Seldin DC, Leder P: The human IL4 receptor shares a critical signal transduction domain with other cytokine receptors. J Cell Biochem 6C:90, 1992 (suppl)
21. Chan SH, Perussia B, GuptaJW, et al: Induction of IFN-gamma production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J Exp Med 173:869, 1991
22. Georgopoulos K, Bigby M, Wang J-H, et al: The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143-156, 1994
23. Malnati MS, Peruzzi M, Parker KC, et al: Peptide specificity in the recognition of class I by Natural Killer cell clones. Science 267:1016-1018, 1995
24. Raulet DH, Held W: Natural Killer cell receptors: the offs and ons of NK recognition. Cell 82:697-700, 1995
25. Guinan EC, Gribben JG, Boussiotis VA, et al: Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261-3282, 1994
26. Phillips JH, Hori T, Nagler A, et al: Ontogeny of human natural killer (NK) cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CDS epsilon, and delta proteins. J Exp Med 175:1055, 1992
27. Hurwitz CA, Raimondi SC, Head D, et al: Distinctive immunophenotypic features of t(8:21) (q22:q22) acute myeloblastic leukemia in children. Blood 80:3182-3188, 1992
28. Van Camp B, Durie BGM, Spier C, et al: Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu19). Blood 76:377-381, 1990
29. Gentile TC, Uner A, Hutchison RE, et al: CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 84:2315-2321, 1994
30. Burg G, Dummer R, Wilhelm M, et al: A subcutaneous delta-positive T-Cell lymphoma that produces interferon gamma. N Engl J Med 325:1078-1082, 1991
31. Adachi M, Maeda K, Takekawa M, et al: High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 47:278-282, 1994
32. Holness CL, Simmons DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81:1607-1613, 1993
33. Warnke RA, Pulford KAF, Pallesen G, et al: Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP-1. AmJ Pathol 135:1089-1095, 1989
34. Carbone A, Gloghini A, Volpe R, et al: KP1 (CD68)-positive large cell lymphomas: A histopathologic and immunophenotypic characterization of 12 cases. HUM PATHOL 24:886-896, 1993
35. Mason DY, Bastard C, Rimokh R, et al: CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161-168, 1990
36. Knapp W, Strobol H, Majdic O: Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 18:187-198, 1994
37. Hamed A, Hruban RH, Gage W, et al: Immunohistochemical expression of CD68 antigen in human peripheral blood T cells. HUM PATHOL 25:872-876, 1994
38. deBruin PC, Jiwa M, Oudejans JJ, et al: Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site. Blood 83:1612-1618, 1994
39. Imashuku S, Hibi S: Cytokines in hemophagocytic syndrome. Br J Haematol 77:438-440, 1994
40. Karasuyama H, Tohyama N, Tada T: Autocrinc growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J Exp Med 169:13-25, 1989
41. Yamada G, Kitamura Y, Sonoda H: Retroviral expression of the human ÏL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBOJ 6:2705-2709, 1987
42. Nagarkatti M, Hassuneh M, Seth A, et al: Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells. Proc Natl Acad Sci U S A 91:7638-7642, 1994
43. Carbonnel F, Lavergne A, Messing B, et al: Extensive small intestinal T-cell iymphoma of low-grade malignancy associated with new chromosomal translocation. Cancer 73:1286-1291, 1994
44. Helfand SC, Modiano JF, Moore PF, et al: Functional Interleukin-2 receptors are expressed on Natural Killer-like leukemic cells from a dog with cutaneous lymphoma. Blood 86:636-645, 1995
45. Wasik MA, Vonderheid EC, Bigler RD, et al: Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma: Clinical and prognostic implications. Arch Dermatol 132:42-47, 1996